4YC:F:F-M3 INC. (EUR)

COMMON STOCK | Health Information Services |

Last Closing

USD 9.2

Change

0.00 (0.00)%

Market Cap

USD 6.89B

Volume

N/A

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-11-02 )

Largest Industry Peers for Health Information Services

Symbol Name Price(Change) Market Cap
L0T:F GE HEALTHCARE TECH.INC.

N/A

USD 37.77B
2HE:F Healthequity Inc

N/A

USD 6.90B
6HL0:F R1 RCM Inc

N/A

USD 5.57B
9EH:F Evolent Health Inc

N/A

USD 2.44B
OC9:F Omnicell Inc

N/A

USD 2.04B
1KJ:F 10X GENOMICS DL -00001

N/A

USD 1.73B
6JM:F JMDC INC.

N/A

USD 1.69B
1XZ:F Ping An Healthcare and Technol..

N/A

USD 1.55B
4LL:F Teladoc Inc

N/A

USD 1.50B
19P:F Phreesia Inc

N/A

USD 0.98B

ETFs Containing 4YC:F

N/A

Market Performance

  Market Performance vs. Industry/Classification (Health Information Services) Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain -36.99% 29% F 18% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -36.99% 29% F 18% F
Trailing 12 Months  
Capital Gain -38.26% 36% F 17% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -38.26% 36% F 17% F
Trailing 5 Years  
Capital Gain N/A N/A N/A N/A N/A
Dividend Return N/A N/A N/A N/A N/A
Total Return N/A N/A N/A N/A N/A
Average Annual (5 Year Horizon)  
Capital Gain -21.72% 21% F 9% A-
Dividend Return 7.64% 76% C+ 56% F
Total Return 29.37% 92% A 86% B+
Risk Return Profile  
Volatility (Standard Deviation) 32.33% 36% F 39% F
Risk Adjusted Return 23.65% 74% C 50% F
Market Capitalization 6.89B 97% N/A 82% B

Annual Financials (EUR)

Quarterly Financials (EUR)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters than its peers, placing it in the top quartile.

Superior total returns

The stock has outperformed its sector peers on average annual total returns basis in the past 5 years (for a hold period of at least 12 months) and is in the top quartile.

High market capitalization

This is one of the largest entities in its sector and is among the top quartile. Such companies tend to be more stable.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

What to not like:
Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

High volatility

The total returns for this company are volatile and above median for its sector over the past 5 years. Make sure you have the risk tolerance for investing in such stock.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.